Skip to main content
SpringerLink
Log in

Comparative analysis of the constituents in Saposhnikoviae Radix and Glehniae Radix cum Rhizoma by monitoring inhibitory activity of nitric oxide production

  • Original Paper
  • Published:
Journal of Natural Medicines Aims and scope Submit manuscript

Abstract

During the development of natural herbal medicines in Japan, Glehniae Radix cum Rhizoma (Hamabofu in Japanese) has been used as a substitute for Saposhnikoviae Radix (Bofu). Bofu and Hamabofu are blended differently in several Kampo formulae. For example, Bofu is included in Jumihaidokuto by a manufacturer, whereas Hamabofu is included instead of Bofu in the same formula by other manufacturers. Although both Bofu and Hamabofu are used for their expected anti-inflammatory effects, differences in their medicinal properties are not well characterized. In addition, there have been very few reports comparing the pharmacological activities of the constituents in Bofu and Hamabofu. In the present study, we investigated the anti-inflammatory effects of the extracts of Bofu and Hamabofu by monitoring levels of the inflammatory mediator nitric oxide (NO) produced in rat hepatocytes. Moreover, the chemical constituents responsible for the activity were investigated. Our results showed that ethyl acetate fractions of Bofu and Hamabofu extracts contain different compounds, although both fractions suppressed NO production in rat hepatocytes. The linear dihydropyranochromones from the Bofu extract (i.e., 3′-O-angeloylhamaudol, ledebouriellol and hamaudol) suppressed NO production, whereas the coumarins from the Hamabofu extract (i.e., umbelliferone and scopoletin) also suppressed NO production. These results suggest that linear dihydropyranochromones and coumarins are responsible for the anti-inflammatory effects of Bofu and Hamabofu. It is plausible that Bofu and Hamabofu are blended differently in several Kampo formulae due to many constituents with as yet unidentified pharmacological activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Li L, Li B, Zhang H, Zhao A, Han B, Liu C, Tsao R (2015) Ultrafiltration LC-ESI-MS screening of MMP-2 inhibitors from selected Chinese medicinal herbs Smilax glabra Roxb., Smilax china L. and Saposhnikovia divaricata (Turcz.) Schischk as potential functional food ingredients. J Funct Food 15:389–395

    Article  CAS  Google Scholar 

  2. Yen KY (1992) The Illustrated Chinese materia medica: crude and prepared. SMC, Taipei, Taiwan, pp 1–340

  3. Wang CC, Chen LG, Yang LL (1999) Inducible nitric oxide synthase inhibitor of the Chinese herb I. Saposhnikovia divaricata (Turcz.) Schischk. Cancer Lett 145:151–157

    Article  CAS  PubMed  Google Scholar 

  4. Su X, Li X, Tao H, Zhou J, Wu T, Chou G, Cheng Z (2013) Simultaneous isolation of seven compounds from Glehnia littoralis roots by off-line overpressured layer chromatography guided by a TLC antioxidant autographic assay. J Sep Sci 36:3644–3650

    Article  CAS  PubMed  Google Scholar 

  5. Ng TB, Liu F, Wang HX (2004) The antioxidant effects of aqueous and organic extracts of Panax quinquefolium, Panax notoginseng, Codonopsis pilosula, Pseudostellaria heterophylla, and Glehnia littoralis. J Ethnopharmacol 93:285–288

    Article  CAS  PubMed  Google Scholar 

  6. Kong CS, Um YR, Lee JI, Yea SS, Seo YW (2010) Constituents isolated from Glehnia littoralis suppress proliferations of human cancer cells and MMP expression in HT1080 cells. Food Chem 120:385–394

    Article  CAS  Google Scholar 

  7. Yuan Z, Tezuka Y, Fan WZ, Kadota S, Li X (2002) Constituents of the underground parts of Glehnia littoralis. Chem Pharm Bull 50:73–77

    Article  CAS  PubMed  Google Scholar 

  8. Okuyama E, Hasegawa T, Matsushita T, Fujimoto H, Ishibashi M, Yamazaki M, Hosokawa M, Hiraoka N, Anetai M, Masuda T, Takasugi M (1998) Analgesic components of Glehnia root (Glehnia littoralis). J Nat Med 52:491–501

    CAS  Google Scholar 

  9. Kitade H, Sakitani K, Inoue K, Masu Y, Kawada N, Hiramatsu Y, Kamiyama Y, Okumura T, Ito S (1996) Interleukin 1β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells. Hepatology 23:797–802

    CAS  PubMed  Google Scholar 

  10. Colasanti R, Suzuki H (2000) The dual personality of NO. Trends Pharmacol Sci 13:249–252

    Article  Google Scholar 

  11. Matsui K, Nishizawa M, Ozaki T, Kimura T, Hashimoto I, Yamada M, Kaibori M, Kamiyama Y, Ito S, Okumura T (2008) Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes. Hepatology 47:686–997

    Article  CAS  PubMed  Google Scholar 

  12. Takimoto Y, Qian HY, Yoshigai E, Okumura T, Ikeya Y, Nishizawa M (2013) Gomisin N in the herbal drug gomishi (Schisandra chinensis) suppresses inducible nitric oxide synthase gene via C/EBPβ and NF-κB in rat hepatocytes. Nitric Oxide 28:47–56

    Article  CAS  PubMed  Google Scholar 

  13. Nakajima A, Yamamoto Y, Yoshinaka N, Namba M, Matsuo H, Okuyama T, Yoshigai E, Okumura T, Nishizawa M, Ikeya Y (2015) A new flavanone and other flavonoids from green perilla leaf extract inhibit nitric oxide production in interleukin 1β-treated hepatocytes. Biosci Biotechnol Biochem 79:138–146

    Article  CAS  PubMed  Google Scholar 

  14. Inaba H, Yoshigai E, Okuyama T, Murakoshi M, Sugiyama K, Nishino H, Nishizawa M (2015) Antipyretic analgesic drugs have different mechanisms for regulation of the expression of inducible nitric oxide synthase in hepatocytes and macrophages. Nitric Oxide 44:61–70

    Article  CAS  PubMed  Google Scholar 

  15. Kanemaki T, Kitade H, Hiramatsu Y, Kamiyama Y, Okumura T (1993) Stimulation of glycogen degradation by prostaglandin E2 in primary cultured rat hepatocytes. Prostaglandins 45:459–474

    Article  CAS  PubMed  Google Scholar 

  16. Green LC, Wanger DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biol Chem 126:131–138

    CAS  Google Scholar 

  17. Sasaki H, Taguchi H, Endo T, Yoshioka I (1982) The constituents of Ledebouriella seseloides WOLFF. I. Structures of three new chromones. Chem Pharm Bull 30:3555–3562

    Article  CAS  Google Scholar 

  18. Park Y, Kim H, Lee S, Choi H, Jin C, Lee Y (2007) A new chromone, 11-Hydroxy-sec-O-glucosylhamaudol from Ostericum koreanum. Chem Pharm Bull 55:1065–1066

    Article  CAS  PubMed  Google Scholar 

  19. Ruo Y, Zhong Y, Yang L (2008) Cytotoxic phenylpropanoids from carrot. J Agric Food Chem 56:3024–3027

    Article  Google Scholar 

  20. Harker S, Razdan TK, Waight ES (1984) Steroids, chromenes and coumarins from Angelica officinalis. Phytochemistry 23:419–426

    Article  Google Scholar 

  21. Kang J, Sun JH, Zhou L, Ye M, Han J, Wang BR, Guo DA (2008) Characterization of compounds from the roots of Saposhnikovia divaricata by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 22:1899–1911

    Article  CAS  PubMed  Google Scholar 

  22. Yang W, Ye M, Liu M, Kong D, Shi R, Shi X, Zhang K, Wang Q, Lantong Z (2010) A practical strategy for the characterization of coumarins in Radix Glehniae by liquid chromatography coupled with triple quadrupole-linear ion trap mass spectrometry. J Chromatogr A 1217:4587–4600

  23. Oda K, Yamaguchi Y, Yoshimura T, Wada K, Nishizono N (2007) Synthetic models related to furanocoumarin-CYP3A4 interactions. comparison of furanocoumarin, coumarin, and benzofuran dimers as potent inhibitors of CYP3A4 activity. Chem Pharm Bull 55:1419–1421

    Article  CAS  PubMed  Google Scholar 

  24. Yamada H, Hanawa T, Kim S (2012) Kampo medical and pharmaceutical sciences for pharmacy student. Nankodo, Tokyo, pp 344–365

    Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Yukinobu Ikeya for his technical advice, and Ms. Kana Nakao for her technical support. This work was supported by a Grant-in-Aid for Promotion of International Research, Ritsumeikan University.

Author information

Authors and Affiliations

  1. Graduate School of Life Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga, 525-8577, Japan

    Takuya Kamino & Toshihiro Shimokura

  2. Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga, 525-8577, Japan

    Takuya Kamino, Toshihiro Shimokura & Mikio Nishizawa

  3. College of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga, 525-8577, Japan

    Takuya Kamino & Ken Tanaka

  4. Graduate School of Information Science, Nara Institute of Science and Technology, Ikoma, Nara, 630-0192, Japan

    Yusuke Morita

  5. Faculty of Pharmaceutical Sciences, Hokuriku University, Ho-3 Kanagawa-machi, Kanazawa, 920-1181, Japan

    Yasuhiro Tezuka

Authors
  1. Takuya Kamino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshihiro Shimokura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yusuke Morita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasuhiro Tezuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mikio Nishizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ken Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ken Tanaka.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kamino, T., Shimokura, T., Morita, Y. et al. Comparative analysis of the constituents in Saposhnikoviae Radix and Glehniae Radix cum Rhizoma by monitoring inhibitory activity of nitric oxide production. J Nat Med 70, 253–259 (2016). https://doi.org/10.1007/s11418-016-0969-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11418-016-0969-1

Keywords

Search

Navigation